Abstract
Polymorphonuclear leucocytes (PMNs), when exposed to the calcium ionophore A23187, release into the supernatant a substance that causes the aggregation and chemokinesis of fresh PMN suspensions. Release of these activities is inhibited by preincubation with drugs known to inhibit lipoxygenase pathways of arachidonic acid metabolism but is unaffected by cyclooxygenase inhibitors. The substance responsible for these activities has been identified as leukotriene B and this compound has been shown to be a potent chemokinetic and aggregatory agent for PMNs over the range 10 pg to 5 ng ml−1.
Similar content being viewed by others
References
R.L. Jones,Pathways of Arachidonic Acid Metabolism, in:Prostaglandins and Inflammation (Eds. K.D. Rainsford and A.W. Ford-Hutchinson; Birkhäuser Verlag, Basel 1979), pp. 19–26.
R.C. Murphy, S. Hammarström andB. Samuelsson,Leukotriene C: a Slow-Reacting Substance from Murine Mastocytoma Cells, Proc. natn. Acad. Sci. USA76, 4275–4279 (1979).
C.W. Parker, B.A. Jakschik, M.G. Huber andS.F. Falkenhein,Characterisation of Slow Reacting Substance as a Family of Thiolipids Derived from Arachidonic Acid, Biochem. Biophys. Res. Commun.89, 1186–1192 (1979).
J.P. Kelly, M.C. Johnson, andC.W. Parker,Effect of Inhibitors of Archidonic Acid Metabolism on Mitogenesis in Human Lymphocytes: a Possible Role of Thromboxanes and Products of the Lipoxygenase Pathway, J. Immunol.122, 1563–1571 (1979).
J.A. Salmon, B.R. Smith, R.J. Flower, S. Moncada andJ.R. Vane, Further Studies on the Enzymatic Conversion of Prostaglandin Endoperoxides into PGI2, Biochim. Biophys. Acta523, 252–262 (1978).
E.J. Goetzl, J.M. Woods andR.R. Gorman, Stimulation of Human Eosinophil and Neutrophil Polymorphonuclear Leucocyte Chemotaxis and Random Migration by 12-l-Hydroxy-5,8,10,14-eicosatetraenoic Acid (HETE). J. Clin. Invest.59, 179–183 (1977).
E.J. Goetzl andF.F. Sun,Generation of Unique Monohydroxy-Eicosatetraenoic Acids from Arachidonic Acid by Human Neutrophils, J. Exp. Med.150, 406–411 (1979).
E.J. Goetzl, P.F. Weller andF.F. Sun,The Regulation of Human Eosinophil Function by Endogenous Mono-hydroxy-eicosatetraenoic Acids (HETEs). J. Immunol.124, 926–933 (1980).
A.W. Ford-Hutchinson, M.A. Bray andM.J.H. Smith,The Aggregation of Rat Neutrophils by Arachidonic Acid: a Possible Bioassay for Lipoxygenase Activity, J. Pharm. Pharmac.12, 868–869 (1979).
J. Smolen andG. Weissman,Lyosomal Enzyme Release from Human Granulocytes is Inhibited by Indomethacin and ETYA. Advances in Prostaglandin and Thromboxane Research8, 1695–1700 (1980).
G.M. Bokoch andP.W. Reed,Inhibition of the Neutrophil Oxidative Response to a Chemotactic Peptide by Inhibitors of Arachidonic Acid Oxygenation, Biochem. Biophys. Res. Commun.90, 481–487 (1979).
G.A. Higgs, R.J. Flower andJ.R. Vane,New Approach to Anti-Inflammatory Drugs, Biochem. Pharmac.28, 1959–1961 (1979).
K.E. Eakins, G.A. Higgs, S. Moncada andK.G. Mugridge,The Effects of Indomethacin and BW755C on Leukocyte Migration, and Prostaglandin Production in Carrageenan-Induced Inflammation, Br. J. Pharmac.69, 270P-271P (1980).
P. Borgeat andB. Samuelsson,Transformation of Arachidonic Acid by Rabbit Polymorphonuclear Leukocytes. Formation of a Novel Dihydroxyeicosatetraenoic Acid, J. Biol. Chem.254, 2643–2646 (1979).
P. Borgeat andB. Samuelsson,Metabolism of Arachidonic Acid in Polymorphonuclear Leucocytes. Structural Analysis of Novel Hydroxylated Compounds, J. Biol. Chem.254, 7865–7869 (1979).
P. Borgeat andB. Samuelsson,Arachidonic Acid Metabolism in Polymorphonuclear Leukocytes: Effects of Ionophore A23187 Proc. natn. Acad. Sci. USA76, 2148–2152 (1979).
W.F. Stenson andC.W. Parker,Metabolism of Arachidonic Acid in Ionophore-Stimulated Neutrophils, J. Clin. Invest.64, 1457–1465 (1979).
M.J.H. Smith andJ.R. Walker,The Effects of Some Anti-Rheumatic Drugs on an in vitro Model of Human Polymorphonuclear Leucocyte Chemokinesis, Br. J. Pharmac.69, 473–478 (1980).
F.M. Cunningham, M.E. Shipley andM.J.H. Smith,Aggregation of Rat Polymorphonuclear Leucocytes in vitro, J. Pharm. Pharmac.32, 377–380 (1980).
M.A. Bray, A.W. Ford-Hutchinson, M.E. Shipley andM.J.H. Smith,Calcium Ionophore A23187 Induces Release of Chemokinetic and Aggregating Factors from Polymorphonuclear Leucocytes, Br. J. Pharmac (1980) (in press).
A.W. Ford-Hutchinson, M.A. Bray, M.E. Shipley, M.V. Doig andM.J.H. Smith,Leukotriene B: a Biologically Active Release Product of Polymorphonuclear Leucocytes, in:Future Trends in Inflammation IV (Eds. D.A. Willoughby, J.P. Giroud and N. Schwartz; M.T.P. Press, London) (in press).
A.W. Ford-Hutchinson, M.A. Bray, M.V. Doig, M.E. Shipley andM.J.H. Smith,Leukotriene B: a Potent Chemokinetic and Aggregating Substance Released from Polymorphonuclear Leucocytes, Nature286, 264–265 (1980).
J.R. Walker, M.J.H. Smith andA.W. Ford-Hutchinson,Anti-Inflammatory Drugs, Prostaglandins and Leucocyte Migration, Agents and Actions6, 602–606 (1976).
A.W. Ford-Hutchinson, J.R. Walker, N.S. Connor, A.M. Oliver andM.J.H. Smith,Separate Anti-Inflammatory Effects of Indomethacin, Flurbiprofen and Benoxaprofen, J. Pharm. Pharmac.29, 372–373 (1977).
A.W. Ford-Hutchinson, J.R. Walker andJ.A. Slack,Aspirin Salicylate and Prostaglandins, Agents and Actions9, 483–487 (1979).
F.H. Valone andE.J. Goetzl,Immunological Release in the Rat Peritoneal Cavity of Lipid Chemotactic and Chemokinetic Factors for Polymorphonuclear Leucocytes, J. Immunol.120, 102–108 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ford-Hutchinson, A.W., Bray, M.A. & Smith, M.J.H. Lipoxygenase products and the polymorphonuclear leucocyte. Agents and Actions 10, 548–550 (1980). https://doi.org/10.1007/BF02024162
Issue Date:
DOI: https://doi.org/10.1007/BF02024162